Literature DB >> 28853495

Epidemiology and Outcome of Squamous Cell Carcinoma in Epidermolysis Bullosa in Australia and New Zealand.

Minhee Kim1, Minmin Li, Lizbeth R A Intong-Wheeler, Kim Tran, Damian Marucci, Dedee F Murrell.   

Abstract

We investigate the epidemiology and outcomes of squamous cell carcinoma (SCC) in recessive dystrophic epidermolysis bullosa (RDEB) from the Australasian EB registry cohort. Seventeen out of 49 (34.6%) RDEB patients developed at least one SCC. Data detailing SCC was obtainable from 16/17 RDEB-SCC patients. A total number of 161 primary SCCs occurred in 16 RDEB-SCC patients with a mean of 10 SCCs per person. The earliest age of first SCC development was 16 years. Eleven out of 16 RDEB-SCC patients eventually developed metastatic SCCs. The majority of the tumours were well and moderately differentiated. The cumulative risk of SCC development by age 35 was 76.1% for RDEB-Generalized Severe (RDEB-GS) and 10% for RDEB-Generalized Intermediate (RDEB-GI). Amongst those who developed SCCs, their median time to death after first SCC was 5 years for RDEB-GI and 4 years for RDEB-GS. This is the first retrospective study of RDEB-SCC in Australasia.

Entities:  

Mesh:

Year:  2018        PMID: 28853495     DOI: 10.2340/00015555-2781

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  11 in total

1.  Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.

Authors:  B Castelo; D Viñal; R Maseda; L Ostios; D Sánchez; B García-Salvatierra; M J Escámez; L Martínez-Santamaría; M Del Río; M Mora-Rillo; Y Vilches; M J Beato; J C López Gutiérrez; N Romero; C Santos; J Miranda; R de Lucas
Journal:  Clin Transl Oncol       Date:  2019-03-12       Impact factor: 3.405

Review 2.  Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature.

Authors:  Domenico Bonamonte; Angela Filoni; Aurora De Marco; Lucia Lospalluti; Eleonora Nacchiero; Valentina Ronghi; Anna Colagrande; Giuseppe Giudice; Gerardo Cazzato
Journal:  Cells       Date:  2022-04-17       Impact factor: 7.666

Review 3.  Toward Combined Cell and Gene Therapy for Genodermatoses.

Authors:  Laura De Rosa; Maria Carmela Latella; Alessia Secone Seconetti; Cecilia Cattelani; Johann W Bauer; Sergio Bondanza; Michele De Luca
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-05-01       Impact factor: 10.005

Review 4.  Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines.

Authors:  K Martin; S Geuens; J K Asche; R Bodan; F Browne; A Downe; N García García; G Jaega; B Kennedy; P J Mauritz; F Pérez; K Soon; V Zmazek; K M Mayre-Chilton
Journal:  Orphanet J Rare Dis       Date:  2019-06-11       Impact factor: 4.123

Review 5.  Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Authors:  Angelo Giuseppe Condorelli; Elena Dellambra; Elena Logli; Giovanna Zambruno; Daniele Castiglia
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

6.  Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.

Authors:  Tania Aguado; Marta García; Adela García; Gemma Ferrer-Mayorga; Lucía Martínez-Santamaría; Marcela Del Río; Luisa-María Botella; José-María Sánchez-Puelles
Journal:  Cells       Date:  2020-09-16       Impact factor: 6.600

Review 7.  A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.

Authors:  Jean Yuh Tang; M Peter Marinkovich; Eleanor Lucas; Emily Gorell; Albert Chiou; Ying Lu; Jodie Gillon; Dipen Patel; Dan Rudin
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

8.  Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.

Authors:  Katharina Woess; Yuchen Sun; Hanae Morio; Anna Stierschneider; Anna Kaufmann; Stefan Hainzl; Lisa Trattner; Thomas Kocher; Birgit Tockner; Victoria Leb-Reichl; Markus Steiner; Gabriele Brachtl; Andrew P South; Johann W Bauer; Julia Reichelt; Tomomi Furihata; Verena Wally; Ulrich Koller; Josefina Piñón Hofbauer; Christina Guttmann-Gruber
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

9.  Detection of Novel Biallelic Causative Variants in COL7A1 Gene by Whole-Exome Sequencing, Resulting in Congenital Recessive Dystrophic Epidermolysis Bullosa in Three Unrelated Families.

Authors:  Fozia Fozia; Rubina Nazli; May Mohammed Alrashed; Hazem K Ghneim; Zia Ul Haq; Musarrat Jabeen; Sher Alam Khan; Ijaz Ahmad; Mohammed Bourhia; Mourad A M Aboul-Soud
Journal:  Diagnostics (Basel)       Date:  2022-06-23

10.  Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.

Authors:  Susan J Robertson; Elizabeth Orrin; Manpreet K Lakhan; Gavin O'Sullivan; Jessie Felton; Alistair Robson; Danielle T Greenblatt; Catina Bernardis; John A McGrath; Anna E Martinez; Jemima E Mellerio
Journal:  Acta Derm Venereol       Date:  2021-08-24       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.